APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nivolumab Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Nivolumab Drugs Market Analysis and Forecast 2026-2032

2 January 2026196 pages

Choose your research edition.

Industry ResearchNivolumab Drugs Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Nivolumab Drugs Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Nivolumab Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nivolumab Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Nivolumab Drugs Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Nivolumab Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Nivolumab Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Nivolumab Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Nivolumab Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Nivolumab Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Nivolumab Drugs include Bristol-Myers Squibb and Ono Pharmaceutical etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Nivolumab Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Nivolumab Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Nivolumab Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nivolumab Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nivolumab Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Nivolumab Drugs sales, projected growth trends, production technology, application and end-user industry.

Nivolumab Drugs Segment by Company

Bristol-Myers Squibb

Ono Pharmaceutical

Nivolumab Drugs Segment by Type

10ml

24ml

4ml

Nivolumab Drugs Segment by Application

Retail Pharmacy

Hospital Pharmacy

Other

Nivolumab Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nivolumab Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nivolumab Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nivolumab Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Nivolumab Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Nivolumab Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nivolumab Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nivolumab Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 10ml Major Manufacturers Table 3. 24ml Major Manufacturers Table 4. 4ml Major Manufacturers Table 5. Global Nivolumab Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Retail Pharmacy Major Manufacturers Table 7. Hospital Pharmacy Major Manufacturers Table 8. Other Major Manufacturers Table 9. Nivolumab Drugs Industry Trends Table 10. Nivolumab Drugs Industry Drivers Table 11. Nivolumab Drugs Industry Opportunities and Challenges Table 12. Nivolumab Drugs Industry Restraints Table 13. Global Nivolumab Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Nivolumab Drugs Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Nivolumab Drugs Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Nivolumab Drugs Revenue Market Share by Region (2021-2026) Table 17. Global Nivolumab Drugs Revenue Market Share by Region (2027-2032) Table 18. Global Nivolumab Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Nivolumab Drugs Sales by Region (2021-2026) & (K Units) Table 20. Global Nivolumab Drugs Sales by Region (2027-2032) & (K Units) Table 21. Global Nivolumab Drugs Sales Market Share by Region (2021-2026) Table 22. Global Nivolumab Drugs Sales Market Share by Region (2027-2032) Table 23. Global Nivolumab Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Nivolumab Drugs Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Nivolumab Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Nivolumab Drugs Sales Market Share by Manufacturers (2021-2026) Table 27. Global Nivolumab Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Nivolumab Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Nivolumab Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Nivolumab Drugs Manufacturers, Product Type & Application Table 31. Global Nivolumab Drugs Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Nivolumab Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Nivolumab Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Nivolumab Drugs Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Nivolumab Drugs Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Nivolumab Drugs Revenue Market Share by Type (2021-2026) Table 38. Global Nivolumab Drugs Revenue Market Share by Type (2027-2032) Table 39. Global Nivolumab Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Nivolumab Drugs Sales by Type (2021-2026) & (K Units) Table 41. Global Nivolumab Drugs Sales by Type (2027-2032) & (K Units) Table 42. Global Nivolumab Drugs Sales Market Share by Type (2021-2026) Table 43. Global Nivolumab Drugs Sales Market Share by Type (2027-2032) Table 44. Global Nivolumab Drugs Price by Type (2021-2026) & (US$/Unit) Table 45. Global Nivolumab Drugs Price by Type (2027-2032) & (US$/Unit) Table 46. Global Nivolumab Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Nivolumab Drugs Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Nivolumab Drugs Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Nivolumab Drugs Revenue Market Share by Application (2021-2026) Table 50. Global Nivolumab Drugs Revenue Market Share by Application (2027-2032) Table 51. Global Nivolumab Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Nivolumab Drugs Sales by Application (2021-2026) & (K Units) Table 53. Global Nivolumab Drugs Sales by Application (2027-2032) & (K Units) Table 54. Global Nivolumab Drugs Sales Market Share by Application (2021-2026) Table 55. Global Nivolumab Drugs Sales Market Share by Application (2027-2032) Table 56. Global Nivolumab Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Nivolumab Drugs Price by Application (2027-2032) & (US$/Unit) Table 58. Bristol-Myers Squibb Company Information Table 59. Bristol-Myers Squibb Business Overview Table 60. Bristol-Myers Squibb Nivolumab Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Bristol-Myers Squibb Nivolumab Drugs Product Portfolio Table 62. Bristol-Myers Squibb Recent Development Table 63. Ono Pharmaceutical Company Information Table 64. Ono Pharmaceutical Business Overview Table 65. Ono Pharmaceutical Nivolumab Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Ono Pharmaceutical Nivolumab Drugs Product Portfolio Table 67. Ono Pharmaceutical Recent Development Table 68. North America Nivolumab Drugs Revenue by Type (2021-2026) & (US$ Million) Table 69. North America Nivolumab Drugs Revenue by Type (2027-2032) & (US$ Million) Table 70. North America Nivolumab Drugs Sales by Type (2021-2026) & (K Units) Table 71. North America Nivolumab Drugs Sales by Type (2027-2032) & (K Units) Table 72. North America Nivolumab Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 73. North America Nivolumab Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 74. North America Nivolumab Drugs Revenue by Application (2021-2026) & (US$ Million) Table 75. North America Nivolumab Drugs Revenue by Application (2027-2032) & (US$ Million) Table 76. North America Nivolumab Drugs Sales by Application (2021-2026) & (K Units) Table 77. North America Nivolumab Drugs Sales by Application (2027-2032) & (K Units) Table 78. North America Nivolumab Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 79. North America Nivolumab Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 80. North America Nivolumab Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 81. North America Nivolumab Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 82. North America Nivolumab Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 83. North America Nivolumab Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 84. North America Nivolumab Drugs Sales by Country (2021-2026) & (K Units) Table 85. North America Nivolumab Drugs Sales by Country (2027-2032) & (K Units) Table 86. North America Nivolumab Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 87. North America Nivolumab Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 88. United States Nivolumab Drugs Revenue (2021-2032) & (US$ Million) Table 89. Canada Nivolumab Drugs Revenue (2021-2032) & (US$ Million) Table 90. Europe Nivolumab Drugs Revenue by Type (2021-2026) & (US$ Million) Table 91. Europe Nivolumab Drugs Revenue by Type (2027-2032) & (US$ Million) Table 92. Europe Nivolumab Drugs Sales by Type (2021-2026) & (K Units) Table 93. Europe Nivolumab Drugs Sales by Type (2027-2032) & (K Units) Table 94. Europe Nivolumab Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 95. Europe Nivolumab Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 96. Europe Nivolumab Drugs Revenue by Application (2021-2026) & (US$ Million) Table 97. Europe Nivolumab Drugs Revenue by Application (2027-2032) & (US$ Million) Table 98. Europe Nivolumab Drugs Sales by Application (2021-2026) & (K Units) Table 99. Europe Nivolumab Drugs Sales by Application (2027-2032) & (K Units) Table 100. Europe Nivolumab Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 101. Europe Nivolumab Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 102. Europe Nivolumab Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Europe Nivolumab Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 104. Europe Nivolumab Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 105. Europe Nivolumab Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 106. Europe Nivolumab Drugs Sales by Country (2021-2026) & (K Units) Table 107. Europe Nivolumab Drugs Sales by Country (2027-2032) & (K Units) Table 108. Europe Nivolumab Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 109. Europe Nivolumab Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 110. Germany Nivolumab Drugs Revenue (2021-2032) & (US$ Million) Table 111. France Nivolumab Drugs Revenue (2021-2032) & (US$ Million) Table 112. U.K. Nivolumab Drugs Revenue (2021-2032) & (US$ Million) Table 113. Italy Nivolumab Drugs Revenue (2021-2032) & (US$ Million) Table 114. Netherlands Nivolumab Drugs Revenue (2021-2032) & (US$ Million) Table 115. China Nivolumab Drugs Revenue by Type (2021-2026) & (US$ Million) Table 116. China Nivolumab Drugs Revenue by Type (2027-2032) & (US$ Million) Table 117. China Nivolumab Drugs Sales by Type (2021-2026) & (K Units) Table 118. China Nivolumab Drugs Sales by Type (2027-2032) & (K Units) Table 119. China Nivolumab Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 120. China Nivolumab Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 121. China Nivolumab Drugs Revenue by Application (2021-2026) & (US$ Million) Table 122. China Nivolumab Drugs Revenue by Application (2027-2032) & (US$ Million) Table 123. China Nivolumab Drugs Sales by Application (2021-2026) & (K Units) Table 124. China Nivolumab Drugs Sales by Application (2027-2032) & (K Units) Table 125. China Nivolumab Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 126. China Nivolumab Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 127. Asia Nivolumab Drugs Revenue by Type (2021-2026) & (US$ Million) Table 128. Asia Nivolumab Drugs Revenue by Type (2027-2032) & (US$ Million) Table 129. Asia Nivolumab Drugs Sales by Type (2021-2026) & (K Units) Table 130. Asia Nivolumab Drugs Sales by Type (2027-2032) & (K Units) Table 131. Asia Nivolumab Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 132. Asia Nivolumab Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 133. Asia Nivolumab Drugs Revenue by Application (2021-2026) & (US$ Million) Table 134. Asia Nivolumab Drugs Revenue by Application (2027-2032) & (US$ Million) Table 135. Asia Nivolumab Drugs Sales by Application (2021-2026) & (K Units) Table 136. Asia Nivolumab Drugs Sales by Application (2027-2032) & (K Units) Table 137. Asia Nivolumab Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 138. Asia Nivolumab Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 139. Asia Nivolumab Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Asia Nivolumab Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 141. Asia Nivolumab Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 142. Asia Nivolumab Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 143. Asia Nivolumab Drugs Sales by Country (2021-2026) & (K Units) Table 144. Asia Nivolumab Drugs Sales by Country (2027-2032) & (K Units) Table 145. Asia Nivolumab Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 146. Asia Nivolumab Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 147. Japan Nivolumab Drugs Revenue (2021-2032) & (US$ Million) Table 148. South Korea Nivolumab Drugs Revenue (2021-2032) & (US$ Million) Table 149. India Nivolumab Drugs Revenue (2021-2032) & (US$ Million) Table 150. Australia Nivolumab Drugs Revenue (2021-2032) & (US$ Million) Table 151. China Taiwan Nivolumab Drugs Revenue (2021-2032) & (US$ Million) Table 152. Southeast Asia Nivolumab Drugs Revenue (2021-2032) & (US$ Million) Table 153. SAMEA Nivolumab Drugs Revenue by Type (2021-2026) & (US$ Million) Table 154. SAMEA Nivolumab Drugs Revenue by Type (2027-2032) & (US$ Million) Table 155. SAMEA Nivolumab Drugs Sales by Type (2021-2026) & (K Units) Table 156. SAMEA Nivolumab Drugs Sales by Type (2027-2032) & (K Units) Table 157. SAMEA Nivolumab Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 158. SAMEA Nivolumab Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 159. SAMEA Nivolumab Drugs Revenue by Application (2021-2026) & (US$ Million) Table 160. SAMEA Nivolumab Drugs Revenue by Application (2027-2032) & (US$ Million) Table 161. SAMEA Nivolumab Drugs Sales by Application (2021-2026) & (K Units) Table 162. SAMEA Nivolumab Drugs Sales by Application (2027-2032) & (K Units) Table 163. SAMEA Nivolumab Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 164. SAMEA Nivolumab Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 165. SAMEA Nivolumab Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. SAMEA Nivolumab Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 167. SAMEA Nivolumab Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 168. SAMEA Nivolumab Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 169. SAMEA Nivolumab Drugs Sales by Country (2021-2026) & (K Units) Table 170. SAMEA Nivolumab Drugs Sales by Country (2027-2032) & (K Units) Table 171. SAMEA Nivolumab Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 172. SAMEA Nivolumab Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 173. Brazil Nivolumab Drugs Revenue (2021-2032) & (US$ Million) Table 174. Argentina Nivolumab Drugs Revenue (2021-2032) & (US$ Million) Table 175. Chile Nivolumab Drugs Revenue (2021-2032) & (US$ Million) Table 176. Colombia Nivolumab Drugs Revenue (2021-2032) & (US$ Million) Table 177. Peru Nivolumab Drugs Revenue (2021-2032) & (US$ Million) Table 178. Saudi Arabia Nivolumab Drugs Revenue (2021-2032) & (US$ Million) Table 179. Israel Nivolumab Drugs Revenue (2021-2032) & (US$ Million) Table 180. UAE Nivolumab Drugs Revenue (2021-2032) & (US$ Million) Table 181. Turkey Nivolumab Drugs Revenue (2021-2032) & (US$ Million) Table 182. Iran Nivolumab Drugs Revenue (2021-2032) & (US$ Million) Table 183. Egypt Nivolumab Drugs Revenue (2021-2032) & (US$ Million) Table 184. Key Raw Materials Table 185. Raw Materials Key Suppliers Table 186. Nivolumab Drugs Distributors List Table 187. Nivolumab Drugs Customers List Table 188. Research Programs/Design for This Report Table 189. Authors List of This Report Table 190. Secondary Sources Table 191. Primary Sources List of Figures Figure 1. Nivolumab Drugs Image Figure 2. Global Nivolumab Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nivolumab Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. 10ml Image Figure 5. 24ml Image Figure 6. 4ml Image Figure 7. Global Nivolumab Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Nivolumab Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 9. Retail Pharmacy Image Figure 10. Hospital Pharmacy Image Figure 11. Other Image Figure 12. Global Nivolumab Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Nivolumab Drugs Revenue (2021-2032) & (US$ Million) Figure 14. Global Nivolumab Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Nivolumab Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Nivolumab Drugs Revenue Market Share by Region (2021-2032) Figure 17. Global Nivolumab Drugs Sales (2021-2032) & (K Units) Figure 18. Global Nivolumab Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Nivolumab Drugs Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Nivolumab Drugs Sales YoY (2021-2032) & (K Units) Figure 21. Europe Nivolumab Drugs Sales YoY (2021-2032) & (K Units) Figure 22. China Nivolumab Drugs Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Nivolumab Drugs Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Nivolumab Drugs Sales YoY (2021-2032) & (K Units) Figure 25. Global Nivolumab Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Nivolumab Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Nivolumab Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Nivolumab Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Nivolumab Drugs Revenue Market Share by Type (2021-2032) Figure 31. Global Nivolumab Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Nivolumab Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Nivolumab Drugs Sales Market Share by Type (2021-2032) Figure 34. Global Nivolumab Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Nivolumab Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Nivolumab Drugs Revenue Market Share by Application (2021-2032) Figure 37. Global Nivolumab Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Nivolumab Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Nivolumab Drugs Sales Market Share by Application (2021-2032) Figure 40. North America Nivolumab Drugs Revenue Share by Type (2021-2032) Figure 41. North America Nivolumab Drugs Sales Share by Type (2021-2032) Figure 42. North America Nivolumab Drugs Revenue Share by Application (2021-2032) Figure 43. North America Nivolumab Drugs Sales Share by Application (2021-2032) Figure 44. North America Nivolumab Drugs Revenue Share by Country (2021-2032) Figure 45. North America Nivolumab Drugs Sales Share by Country (2021-2032) Figure 46. Europe Nivolumab Drugs Revenue Share by Type (2021-2032) Figure 47. Europe Nivolumab Drugs Sales Share by Type (2021-2032) Figure 48. Europe Nivolumab Drugs Revenue Share by Application (2021-2032) Figure 49. Europe Nivolumab Drugs Sales Share by Application (2021-2032) Figure 50. Europe Nivolumab Drugs Revenue Share by Country (2021-2032) Figure 51. Europe Nivolumab Drugs Sales Share by Country (2021-2032) Figure 52. China Nivolumab Drugs Revenue Share by Type (2021-2032) Figure 53. China Nivolumab Drugs Sales Share by Type (2021-2032) Figure 54. China Nivolumab Drugs Revenue Share by Application (2021-2032) Figure 55. China Nivolumab Drugs Sales Share by Application (2021-2032) Figure 56. Asia Nivolumab Drugs Revenue Share by Type (2021-2032) Figure 57. Asia Nivolumab Drugs Sales Share by Type (2021-2032) Figure 58. Asia Nivolumab Drugs Revenue Share by Application (2021-2032) Figure 59. Asia Nivolumab Drugs Sales Share by Application (2021-2032) Figure 60. Asia Nivolumab Drugs Revenue Share by Country (2021-2032) Figure 61. Asia Nivolumab Drugs Sales Share by Country (2021-2032) Figure 62. SAMEA Nivolumab Drugs Revenue Share by Type (2021-2032) Figure 63. SAMEA Nivolumab Drugs Sales Share by Type (2021-2032) Figure 64. SAMEA Nivolumab Drugs Revenue Share by Application (2021-2032) Figure 65. SAMEA Nivolumab Drugs Sales Share by Application (2021-2032) Figure 66. SAMEA Nivolumab Drugs Revenue Share by Country (2021-2032) Figure 67. SAMEA Nivolumab Drugs Sales Share by Country (2021-2032) Figure 68. Nivolumab Drugs Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Nivolumab Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 10ml
  • 24ml
  • 4ml
Applications
  • Retail Pharmacy
  • Hospital Pharmacy
  • Other
Companies covered
  • Bristol-Myers Squibb
  • Ono Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Nivolumab Drugs Market by Type
  3. 1.2.1 Global Nivolumab Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 10ml
  5. 1.2.3 24ml
  6. 1.2.4 4ml
  7. 1.3 Nivolumab Drugs Market by Application
  8. 1.3.1 Global Nivolumab Drugs Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Retail Pharmacy
  10. 1.3.3 Hospital Pharmacy
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Nivolumab Drugs Market Dynamics
  1. 2.1 Nivolumab Drugs Industry Trends
  2. 2.2 Nivolumab Drugs Industry Drivers
  3. 2.3 Nivolumab Drugs Industry Opportunities and Challenges
  4. 2.4 Nivolumab Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Nivolumab Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Nivolumab Drugs Revenue by Region
  3. 3.2.1 Global Nivolumab Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Nivolumab Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Nivolumab Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Nivolumab Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Nivolumab Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Nivolumab Drugs Sales by Region
  9. 3.4.1 Global Nivolumab Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Nivolumab Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Nivolumab Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Nivolumab Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Nivolumab Drugs Revenue by Manufacturers
  2. 4.1.1 Global Nivolumab Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Nivolumab Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Nivolumab Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Nivolumab Drugs Sales by Manufacturers
  6. 4.2.1 Global Nivolumab Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Nivolumab Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Nivolumab Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Nivolumab Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Nivolumab Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Nivolumab Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Nivolumab Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Nivolumab Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Nivolumab Drugs Market CR5 and HHI
  16. 4.8.2 2025 Nivolumab Drugs Tier 1, Tier 2, and Tier 3
5 Nivolumab Drugs Market by Type
  1. 5.1 Global Nivolumab Drugs Revenue by Type
  2. 5.1.1 Global Nivolumab Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Nivolumab Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Nivolumab Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Nivolumab Drugs Sales by Type
  6. 5.2.1 Global Nivolumab Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nivolumab Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Nivolumab Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Nivolumab Drugs Price by Type
6 Nivolumab Drugs Market by Application
  1. 6.1 Global Nivolumab Drugs Revenue by Application
  2. 6.1.1 Global Nivolumab Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Nivolumab Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Nivolumab Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Nivolumab Drugs Sales by Application
  6. 6.2.1 Global Nivolumab Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Nivolumab Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Nivolumab Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Nivolumab Drugs Price by Application
7 Company Profiles
  1. 7.1 Bristol-Myers Squibb
  2. 7.1.1 Bristol-Myers Squibb Company Information
  3. 7.1.2 Bristol-Myers Squibb Business Overview
  4. 7.1.3 Bristol-Myers Squibb Nivolumab Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Bristol-Myers Squibb Nivolumab Drugs Product Portfolio
  6. 7.1.5 Bristol-Myers Squibb Recent Developments
  7. 7.2 Ono Pharmaceutical
  8. 7.2.1 Ono Pharmaceutical Company Information
  9. 7.2.2 Ono Pharmaceutical Business Overview
  10. 7.2.3 Ono Pharmaceutical Nivolumab Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Ono Pharmaceutical Nivolumab Drugs Product Portfolio
  12. 7.2.5 Ono Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Nivolumab Drugs Market Size by Type
  2. 8.1.1 North America Nivolumab Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Nivolumab Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Nivolumab Drugs Price by Type (2021-2032)
  5. 8.2 North America Nivolumab Drugs Market Size by Application
  6. 8.2.1 North America Nivolumab Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Nivolumab Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Nivolumab Drugs Price by Application (2021-2032)
  9. 8.3 North America Nivolumab Drugs Market Size by Country
  10. 8.3.1 North America Nivolumab Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Nivolumab Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Nivolumab Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Nivolumab Drugs Market Size by Type
  2. 9.1.1 Europe Nivolumab Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Nivolumab Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Nivolumab Drugs Price by Type (2021-2032)
  5. 9.2 Europe Nivolumab Drugs Market Size by Application
  6. 9.2.1 Europe Nivolumab Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Nivolumab Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Nivolumab Drugs Price by Application (2021-2032)
  9. 9.3 Europe Nivolumab Drugs Market Size by Country
  10. 9.3.1 Europe Nivolumab Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Nivolumab Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Nivolumab Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Nivolumab Drugs Market Size by Type
  2. 10.1.1 China Nivolumab Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Nivolumab Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Nivolumab Drugs Price by Type (2021-2032)
  5. 10.2 China Nivolumab Drugs Market Size by Application
  6. 10.2.1 China Nivolumab Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Nivolumab Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Nivolumab Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Nivolumab Drugs Market Size by Type
  2. 11.1.1 Asia Nivolumab Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Nivolumab Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Nivolumab Drugs Price by Type (2021-2032)
  5. 11.2 Asia Nivolumab Drugs Market Size by Application
  6. 11.2.1 Asia Nivolumab Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Nivolumab Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Nivolumab Drugs Price by Application (2021-2032)
  9. 11.3 Asia Nivolumab Drugs Market Size by Country
  10. 11.3.1 Asia Nivolumab Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Nivolumab Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Nivolumab Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Nivolumab Drugs Market Size by Type
  2. 12.1.1 SAMEA Nivolumab Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Nivolumab Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Nivolumab Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Nivolumab Drugs Market Size by Application
  6. 12.2.1 SAMEA Nivolumab Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Nivolumab Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Nivolumab Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Nivolumab Drugs Market Size by Country
  10. 12.3.1 SAMEA Nivolumab Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Nivolumab Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Nivolumab Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Nivolumab Drugs Value Chain Analysis
  2. 13.1.1 Nivolumab Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Nivolumab Drugs Production Mode & Process
  6. 13.2 Nivolumab Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Nivolumab Drugs Distributors
  9. 13.2.3 Nivolumab Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst